Transforming Growth Factor Beta Type I Role in Neurodegeneration: Implications for Alzheimer´s Disease
The DOI matches its Crossref record.
Abstract
Alzheimer's disease is a neurodegenerative condition affecting millions of people worldwide. Alzheimer's symptoms include memory loss and cognitive decline. Pathologically, the hallmarks of Alzheimer´s are the presence of Amyloid beta-plaques, neurofibrillary tangles, and neuronal loss. Unfortunately, no cure is presently available and current treatments are only symptomatic. Transforming growth factor beta type I (TGF-β1) is a trophic factor involved in neuronal development and synaptic plasticity. Impairment of TGF-β1 signaling is associated with exacerbated Aβ deposition and neurofibrillary tangle formation, which increases neurodegeneration. Aging and chronic inflammation reduce the canonical TGF-β1/Smad signaling, facilitating cytotoxic activation of microglia and microgliamediated neurodegeneration This review gathers together evidence for a neuroprotective role of TGF-β in Alzheimer's disease. Restoring TGF-β1 signaling impairment may be a new pharmacological strategy Alzheimer's treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Puntambekar, S. S., Moutinho, M., Lin, P. B.-C., Jadhav, V., Tumbleson-Brink, D., Balaji, A., Benito, M. A., Xu, G., Oblak, A., Lasagna-Reeves, C. A., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00545-9 · Cited by 113
“3Biv, Bv), signaling components that have been implicated in a protective microglial phenotype [35].”
BackgroundThe Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer’s Disease
Ogunmokun, G., Dewanjee, S., Chakraborty, P., Valupadas, C., Chaudhary, A., Kolli, V., Anand, U., Vallamkondu, J., Goel, P., Paluru, H. P. R., et al. (2021) · Cells · doi:10.3390/cells10102790 · Cited by 85
“10 TGF-β1 Increases APP mRNA, increases Aβ deposition [10,42,43] 11 CCL2 Increases Aβ formation and deposition [44,45] 12 CCL3 Upregulates β-secretase, increases C99, increases Aβ deposition [45,46] 13 CCL5 Upregulates β-secretase, increase C99, increases Aβ deposition [46,47] 14 CXCL10 Decreases Aβ deposition [34,48]…”
BackgroundLista, S., Imbimbo, B. P., Grasso, M., Fidilio, A., Emanuele, E., Minoretti, P., López-Ortiz, S., Martín-Hernández, J., Gabelle, A., Caruso, G., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03163-y · Cited by 81
“Building on the evidence obtained from AD patients, various studies have been conducted in animal models of AD to validate the role of TGF-β1 as both a novel biomarker and a potential pharmacological target [136].”
BackgroundTGF-β/Smad Signalling in Neurogenesis: Implications for Neuropsychiatric Diseases
Hiew, L.-F., Poon, C.-H., You, H.-Z., & Lim, L.-W. (2021) · Cells · doi:10.3390/cells10061382 · Cited by 71
Unveiling the Complex Role of Exosomes in Alzheimer’s Disease
Sun, M., & Chen, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s466821 · Cited by 39
“132 Collectively, these results suggest that exosomes may transport pathogenic proteins associated with Alzheimer’s disease and lead to dysfunction in neuronal activity.”
Background
Metadata
- Authors
- Estrada, L. D., Oliveira-Cruz, L., & Cabrera, D.
- Venue
- Current Protein & Peptide Science
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2018-10-04
- Volume
- 19
- Issue
- 12
- Pages
- 1180-1188
- ISSN
- 1389-2037 (ISSN-L)
- OpenAlex
- W2784577144
- Cited by
- 59
- References
- 0
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transforming Growth Factor Beta Type I Role in Neurodegeneration: Implications for Alzheimer´s Disease. https://app.cochat.ai/papers/10.2174/1389203719666171129094937
- The paper
- Estrada, L. D., Oliveira-Cruz, L., & Cabrera, D. (2018). Transforming Growth Factor Beta Type I Role in Neurodegeneration: Implications for Alzheimer´s Disease. Current Protein & Peptide Science. https://doi.org/10.2174/1389203719666171129094937
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.